Skip to content

NANOVIRICIDES, INC.: 10-Q filed 2012-02-14

What NANOVIRICIDES, INC. reported in its quarterly report filed 2012-02-14 (fiscal Q2 2012): 22 published measures, 89 facts as tagged in accession 0001144204-12-008747.

This filing

Form
10-Q (quarterly report)
Filed
2012-02-14
Fiscal period
fiscal Q2 2012
Accession
0001144204-12-008747 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-3113,561,230USD
At 2011-06-3010,758,067USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-3112,388,239USD
At 2011-06-3010,170,891USD
At 2010-06-306,518,704USD
At 2009-06-302,485,542USD
At 2008-06-30443,739USD
At 2007-06-30500,338USD
At 2006-06-301,238,456USD
At 2005-06-30-66,005USD
At 2005-05-110USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-3112,099,083USD
At 2011-06-309,224,023USD
At 2010-12-318,994,772USD
At 2010-09-307,677,554USD
At 2010-06-306,955,733USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-1,391,319USD92
2011-07-01 to 2011-12-31-2,531,295USD184
2005-05-12 to 2011-12-31-25,748,204USD2425
2010-07-01 to 2011-06-30-6,477,166USD365
2010-10-01 to 2010-12-31-1,575,365USD92
2010-07-01 to 2010-12-31-2,672,857USD184
2009-07-01 to 2010-06-30-4,744,208USD365
2008-07-01 to 2009-06-30-2,787,798USD365
2007-07-01 to 2008-06-30-2,738,337USD366
2006-07-01 to 2007-06-30-3,118,963USD365
2005-07-01 to 2006-06-30-3,284,432USD365
2005-05-12 to 2005-06-30-66,005USD50

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-07-01 to 2011-12-31-1,902,472USD184
2005-05-12 to 2011-12-31-17,846,687USD2425
2010-07-01 to 2010-12-31-2,448,148USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-07-01 to 2011-12-3123,352USD184
2005-05-12 to 2011-12-311,440,717USD2425
2010-07-01 to 2010-12-31106,686USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-07-01 to 2011-12-314,824,875USD184
2005-05-12 to 2011-12-3131,834,233USD2425
2010-07-01 to 2010-12-314,620,000USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-07-01 to 2011-12-31-47,343USD184
2005-05-12 to 2011-12-31-1,888,463USD2425
2010-07-01 to 2010-12-31-132,813USD184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-10-01 to 2011-12-310USD92
2011-07-01 to 2011-12-310USD184
2005-05-12 to 2011-12-310USD2425
2010-10-01 to 2010-12-310USD92
2010-07-01 to 2010-12-310USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-31720,281USD
At 2011-06-30802,367USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-1,337,064USD92
2011-07-01 to 2011-12-31-2,457,715USD184
2005-05-12 to 2011-12-31-25,183,653USD2425
2010-10-01 to 2010-12-31-1,498,914USD92
2010-07-01 to 2010-12-31-2,610,259USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-3112,421,963USD
At 2011-06-309,556,317USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-311,172,992USD
At 2011-06-30587,176USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-10-01 to 2011-12-311,337,064USD92
2011-07-01 to 2011-12-312,457,715USD184
2005-05-12 to 2011-12-3125,183,653USD2425
2010-10-01 to 2010-12-311,498,914USD92
2010-07-01 to 2010-12-312,610,259USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-10-01 to 2011-12-311,011,466USD92
2011-07-01 to 2011-12-311,670,040USD184
2005-05-12 to 2011-12-3115,915,258USD2425
2010-10-01 to 2010-12-311,114,647USD92
2010-07-01 to 2010-12-311,872,475USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-31149,765,873shares
At 2011-06-30143,548,394shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-3137,978,376USD
At 2011-06-3033,235,990USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-12-31418,986USD
At 2011-06-30399,383USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-3148,288USD
At 2011-06-3027,173USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-1,391,319USD92
2011-07-01 to 2011-12-31-2,531,295USD184
2005-05-12 to 2011-12-31-25,748,204USD2425
2010-10-01 to 2010-12-31-1,575,365USD92
2010-07-01 to 2010-12-31-2,672,857USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-10-01 to 2011-12-31325,598USD92
2011-07-01 to 2011-12-31787,675USD184
2005-05-12 to 2011-12-319,689,237USD2425
2010-10-01 to 2010-12-31384,267USD92
2010-07-01 to 2010-12-31737,784USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-10-01 to 2011-12-31-54,255USD92
2011-07-01 to 2011-12-31-73,580USD184
2005-05-12 to 2011-12-31-564,551USD2425
2010-10-01 to 2010-12-31-76,451USD92
2010-07-01 to 2010-12-31-62,598USD184

Inspect the source

Entity
NANOVIRICIDES, INC. / CIK 0001379006
Captured
2026-09-20T07:58:03.748Z
SEC response SHA-256
5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))